Hanmi Pharm. Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	116,484	121,315	146,231	82,792	67,025	11,959
Depreciation & Amortization	97,935	97,331	98,454	96,842	89,086	61,339
Loss (Gain) From Sale of Assets	-66.41	-27.74	-1,769	-451.65	1,062	313.72
Asset Writedown & Restructuring Costs	2,441	2,488	9,153	3,794	535.2	-470.68
Loss (Gain) From Sale of Investments	1,238	87.92	-2,630	-47.09	-	4,514
Loss (Gain) on Equity Investments	6.44	9.2	-1,258	8,537	4.02	0.02
Provision & Write-off of Bad Debts	-2,313	-593.89	1,277	723.06	5,118	374.19
Other Operating Activities	45,595	63,140	24,476	43,766	92,609	31,431
Change in Accounts Receivable	-35,391	-61,052	-3,217	37,286	-76,613	32,478
Change in Inventory	-27,815	1,928	-16,903	-14,365	18,916	4,885
Change in Accounts Payable	-368.95	-10,438	5,574	-2,736	9,794	-5,308
Change in Other Net Operating Assets	-24,423	-20,701	-42,852	-93,870	-5,613	10,020
Operating Cash Flow	173,321	193,487	216,538	162,269	201,923	151,535
Operating Cash Flow Growth	-22.24%	-10.64%	33.44%	-19.64%	33.25%	1117.48%
Capital Expenditures	-45,435	-39,261	-27,352	-30,378	-19,949	-41,815
Sale of Property, Plant & Equipment	524.65	50.86	2,600	1,397	86.37	80.8
Sale (Purchase) of Intangibles	-24,918	-22,768	-16,156	-20,273	-14,199	-15,935
Investment in Securities	49,805	103,827	-138,865	-118,609	-6,953	13,994
Other Investing Activities	-6,483	-3,650	-3,699	-13,545	-2,375	-1,491
Investing Cash Flow	-40,710	24,851	-183,472	-181,408	-43,389	-45,166
Short-Term Debt Issued	-	431,830	134,650	230,000	102,700	159,200
Long-Term Debt Issued	-	49,000	-	7,000	30,000	21,800
Total Debt Issued	265,000	480,830	134,650	237,000	132,700	181,000
Short-Term Debt Repaid	-	-472,330	-202,650	-116,800	-198,800	-184,200
Long-Term Debt Repaid	-	-86,431	-37,720	-147,240	-36,476	-50,766
Total Debt Repaid	-336,653	-558,761	-240,370	-264,040	-235,276	-234,966
Net Debt Issued (Repaid)	-71,653	-77,931	-105,720	-27,040	-102,576	-53,966
Repurchase of Common Stock	-	-3,280	-3,071	-3,834	-4,874	-3,083
Dividends Paid	-30,856	-12,555	-17,996	-5,992	-5,881	-8,140
Other Financing Activities	-	-	-0	-	-	-
Financing Cash Flow	-102,509	-93,767	-126,787	-36,867	-113,331	-65,190
Foreign Exchange Rate Adjustments	6,114	12,727	1,373	-5,890	17,864	-1,134
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-	-
Net Cash Flow	36,215	137,297	-92,348	-61,896	63,067	40,044
Free Cash Flow	127,886	154,226	189,186	131,890	181,974	109,719
Free Cash Flow Growth	-31.93%	-18.48%	43.44%	-27.52%	65.85%	-
Free Cash Flow Margin	8.72%	10.31%	12.69%	9.90%	15.12%	10.20%
Free Cash Flow Per Share	10085.73	12162.13	14906.67	10382.37	14307.73	8617.07
Cash Interest Paid	18,723	24,747	27,846	19,498	18,315	23,596
Cash Income Tax Paid	41,377	22,120	31,432	29,632	6,599	14,693
Levered Free Cash Flow	95,114	132,235	156,408	193,044	159,618	64,927
Unlevered Free Cash Flow	106,835	147,468	174,226	207,199	169,979	80,469
Change in Working Capital	-87,998	-90,263	-57,397	-73,686	-53,516	42,074

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.